Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.
about
Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinomaPilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancerPilot study of hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for patients with postoperative liver metastases from pancreatic cancer.Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191Chemoradiation in pancreatic adenocarcinoma: a literature review.Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer.Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis.Endoscopic ultrasound-guided fine needle aspiration of pancreatic masses: the utility and impact on management of patients.Hepatic arterial infusion chemotherapy for post-operative liver metastases from pancreatic cancer in a patient with leukocytopenia: A case report.Immunological impact of neoadjuvant chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma.Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study.Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection.Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.
P2860
Q33383909-B7FC9296-3583-44CD-AF9E-58FD138B6AA1Q33403255-488CF2DB-0B5E-4720-8567-8DA2F30B473BQ33403304-2E9EA1B5-1E7E-44BE-BBE2-C0B962DC45CAQ33755147-AF614BAC-8995-4600-8427-7A7BEC540808Q35583949-217A10D0-10EC-4FA5-A6DF-ECDF9C69C48DQ37347058-50CD3DC4-D809-40D1-95EE-7ED605AA9971Q38173993-95AD373F-8DC0-4011-AE8D-11AC0537D96DQ39941534-C3283C5D-A650-4FF1-8C4B-290301EE0B51Q42326158-131DCDBF-60FB-45AE-BEE6-0B89A835E273Q45086471-2E067627-DD99-4FAD-82D8-8F48FE9B8D28Q47319862-0C2BA7B3-BB4A-4027-8F71-8A32BFB0EB4DQ53270915-149E190F-1FC4-420A-92E9-9829B9F5598CQ53669098-FD83F237-4EDE-4A04-BF90-AFF8507042F8Q55634822-F91F397D-796F-4C91-AB0F-4EFC42C1E2EE
P2860
Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.
@ast
Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.
@en
type
label
Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.
@ast
Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.
@en
prefLabel
Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.
@ast
Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.
@en
P2093
P1433
P1476
Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.
@en
P2093
Hideyoshi Toyokawa
Hiroaki Yanagimoto
Hiroshi Araki
Kanji Takahashi
Mitsuharu Sohgawa
Naoyoshi Terakawa
Sohei Satoi
Soichiro Takai
Yasuo Kamiyama
Youichi Matsui
P304
P356
10.1097/MPA.0B013E31814B229A
P577
2008-01-01T00:00:00Z